Adoption of a plant-based diet by patients with recurrent prostate cancer

Integrative Cancer Therapies

Volumn 5, Issue 3, 2006, Pages 214-223

  Nguyen, Jacquelyn Y ^a   Major, Jacqueline M ^b   Knott, Cynthia J ^b   Freeman, Karen M ^c   Downs, Tracy M ^c   Saxe, Gordon A ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Complementary and alternative medicine; Disease progression; Plant based diet; Prostate; Prostate specific antigen; Prostatic neoplasms; PSA doubling time; Rising PSA; Stress reduction

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FOOD INTAKE; GRAIN; HUMAN; MALE; MEDICAL RECORD; PILOT STUDY; PLANT; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; SPOUSE; STRESS; TREATMENT INDICATION; TREATMENT OUTCOME; VEGETABLE;

AGED; AGED, 80 AND OVER; DIET, VEGETARIAN; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 33746615922     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406292053     Document Type: Article

References (38)

1. Pienta KJ. Etiology, epidemiology, and prevention of carcinoma of the prostate. In: Walsh PC, ed. Campbell's Urology. 7th ed. Philadelphia, Pa: Saunders; 1998:2489-2496.
2. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591-1597.
3. Patel A, Dorey F, Franklin J, deKernion JB. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol. 1997;158:1441-1445.
4. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 1997;44:213-221.
5. D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen M-H. Surrogate end-point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst. 2003;95:1376-1383.
6. Vollmer RT, Dawson NA, Vogelzang NJ. The dynamics of prostate specific antigen in hormone refractory prostate carcinoma: an analysis of cancer and leukemia group B study 9181 of megestrol acetate. Cancer. 1998;83:1989-1994.
7. Messing EM, Manola J, Sarosoy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341:1781-1788.
8. Mayer FJ, Crawford ED. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy. Urol Clin North Am. 1994;21:707-715.
9. Heber D, Fair WR, Ornish D. Nutrition and Prostate Cancer: A Monograph From the CaPCure Nutrition Project. 2nd ed. Santa Monica, Calif: Association for the Cure of Cancer of the Prostate; 1998.
10. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol 7, IARC Scientific Publications #143. Oxford, UK: Oxford University Press.
11. Shimuzu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and White immigrants to Los Angeles County. Br J Cancer. 1991;63:963-966.
12. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer: geographical distributions and time-trends. Acta Oncol. 1991;30:133-140.
13. Fair WR, Fleshner NE, Heston WD. Cancer of the prostate: a nutritional disease? Urology. 1997;50:840-848.
14. Pienta K, Esper P. Risk factors for prostate cancer. Ann Intern Med. 1993;118:793-803.
15. Nomura AMY, Kolonel LN. Prostate cancer: a current perspective. Am J Epidemiol. 1991;13:200-227.
16. Hickey K, Do K-A, Green A. Smoking and prostate cancer. Epidemiol Rev. 2001;23:115-125.
17. Lee I-M, Sesso HD, Chen J-J, Paffenberger RS. Does physical activity play a role in the prevention of prostate cancer? Epidemiol Rev. 2001;23:132-137.
18. Strickler HD, Goedert JJ. Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev. 2001;23:144-151.
19. Mandel JS, Schuman LM. Sexual factors and prostatic cancer. J Gerontol. 1987;42:259-264.
20. Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors. Prostate. 1990;17:269-279.
21. Herbert JT, Birkhoff JD, Feorino PM. et al. Herpes simplex type 2 and cancer of the prostate. J Urol. 1976;116:611-612.
22. Baker LH, Mebust WK, Chin TD, et al. The relationship of herpesvirus to carcinoma of the prostate. J Urol. 1981;125:370-374.
23. Giovannucci E. Medical history and etiology of prostate cancer. Epidemiol Rev. 2001;23:159-162.
24. Parent M-E, Siemiatycki J. Occupation and prostate cancer. Epidemiol Rev. 2001;23:138-143.
25. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23:72-81.
26. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 2001;23:87-92.
27. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun. 1997;233:418-423.
28. Chan J, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001;23:82-6.
29. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intake and prostate cancer risk. J Natl Cancer Inst. 2000;92:61-68.
30. Brooks JD, Paton VG, Vidanes G. Potent induction of phase 2 enzymes in human prostate cancer cells by sulforaphane. Cancer Epidemiol Biomarkers Prev. 2001;10:949-954.
31. Carter JP, Saxe GA, Newbold V, Peres CE, Campeau RJ, Bernal-Green L. Hypothesis: dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. J Am Coll Nutr. 1993;12:209-226.
32. Saxe GA, Hebert JR, Carmody JF, et al. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol. 2001;166:2202-2207.
33. Ornish D, Weidner G, Fair W, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174:1065-1070.
34. Thomson CA, Giuliano A, Rock CL, et al. Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am J Epidemiol. 2003;157:754-762.
35. Newman V, Rock CL, Faerber S, Flatt SW, Wright FA, Pierce JP. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc. 1998;98:285-292.
36. Saxe GA, Major JM, Nguyen JY, Freeman KM, Downs TM, Salem CE. Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction. Integr Cancer Ther. 2006;5:206-213.
37. Daubenmier JJ, Weidner G, Marlin R, et al. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006;67:125-130.
38. Amling CL. The association between obesity and progression of prostate and renal cell carcinoma. Urol Oncol. 2004;22:478-484.